|
An Additional Exempt Distribution -2022-06-07
|
5
|
Resverlogix Corp.
|
Jun 08, 2022 11:53AM
|
|
Patent Applications in U.S. and Europe
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 24, 2019 04:20PM
|
|
"ORI" SEDI Insider Report
|
4
|
Resverlogix Corp.
|
Jan 11, 2022 09:08AM
|
|
"UTS RESVERLOGIX 1 COM & 1 WT" one entry @ $4
|
1
|
Resverlogix Corp.
|
Jun 08, 2019 11:16AM
|
|
"ZHCLF" TRADING
|
|
Zenith Epigenetics
|
Oct 20, 2021 12:15PM
|
|
57th ERA-EDTA Congress Abstracts
|
6
|
Resverlogix Corp.
|
Jun 08, 2020 05:04AM
|
|
A change to the position of CMO at BTI
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 05, 2020 10:33AM
|
|
ABL- COVID-19 Therapeutic
|
2
|
Resverlogix Corp.
|
Mar 07, 2021 08:01AM
|
|
ACCORDING TO "GlobalData" https://www.globalda...
|
3
|
Resverlogix Corp.
|
Oct 26, 2023 08:02AM
|
|
Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Oct 23, 2023 05:17PM
|
|
Additional Exempt Distribution- 2023-03-31
|
5
|
Zenith Epigenetics
|
Apr 10, 2023 07:09PM
|
|
Additional Exempt Distribution- 2023-04-28
|
3
|
Zenith Epigenetics
|
May 09, 2023 09:33AM
|
|
Additional Exempt Distribution- 2023-05-11
|
3
|
Zenith Epigenetics
|
Jun 02, 2023 08:38AM
|
|
Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Sep 17, 2023 04:45PM
|
|
Additional Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Mar 18, 2023 11:39AM
|
|
Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 05, 2023 06:22AM
|
|
Additional Reports of Exempt Distribution - 2023-04-28
|
3
|
Resverlogix Corp.
|
May 05, 2023 04:17PM
|
|
Additional Reports of Exempt Distribution - 2023-05-15
|
3
|
Resverlogix Corp.
|
May 29, 2023 06:08AM
|
|
AGM
|
|
Zenith Epigenetics
|
Jun 21, 2021 05:36AM
|
|
AGM 2024
|
3
|
Resverlogix Corp.
|
Apr 19, 2024 07:12AM
|
